- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Zogenix Inc+ Add to Watchlist
ZGNX:US1.5400 USD 0.0200 1.32%
As of 11:29:18 ET on 05/22/2013.
Company Profile for Zogenix Inc (ZGNX)
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
Key Executives for Zogenix Inc (ZGNX)
|Roger L HawleyCEO/Co-Founder||Stephen J FarrPresident|
|Cynthia Y RobinsonChief Development Officer||Ann D RhoadsExec VP/CFO/Treasurer/Secy|
|Richard Scott ShivelyExec VP/Chief Commercial Ofcr||John J TuraninVP/General Mgr:Zogenix Tech|
|Bret E MegargelVP:Corporate Dev/Co-Founder||Stephen H JennerVP:Marketing|
|Edward F Smith IIIVP:Regulatory Affairs & Drug||Mark R ThompsonVP:Sales & Managed Markets|
|Jeff D DurflingerVP:Technical Ops & Product Supply|